DE2535023A1 - Neue oxazolidinone, verfahren zu ihrer herstellung, und ihre verwendung in arzneimitteln - Google Patents

Neue oxazolidinone, verfahren zu ihrer herstellung, und ihre verwendung in arzneimitteln

Info

Publication number
DE2535023A1
DE2535023A1 DE19752535023 DE2535023A DE2535023A1 DE 2535023 A1 DE2535023 A1 DE 2535023A1 DE 19752535023 DE19752535023 DE 19752535023 DE 2535023 A DE2535023 A DE 2535023A DE 2535023 A1 DE2535023 A1 DE 2535023A1
Authority
DE
Germany
Prior art keywords
formula
compound
compounds
dose
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752535023
Other languages
German (de)
English (en)
Inventor
Richard Rips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Santé et de la Recherche Médicale filed Critical Institut National de la Santé et de la Recherche Médicale
Publication of DE2535023A1 publication Critical patent/DE2535023A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19752535023 1974-08-09 1975-08-06 Neue oxazolidinone, verfahren zu ihrer herstellung, und ihre verwendung in arzneimitteln Withdrawn DE2535023A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7427702A FR2281114A1 (fr) 1974-08-09 1974-08-09 Oxazolidinones, leur preparation et leurs applications

Publications (1)

Publication Number Publication Date
DE2535023A1 true DE2535023A1 (de) 1976-03-04

Family

ID=9142294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752535023 Withdrawn DE2535023A1 (de) 1974-08-09 1975-08-06 Neue oxazolidinone, verfahren zu ihrer herstellung, und ihre verwendung in arzneimitteln

Country Status (6)

Country Link
JP (1) JPS5143757A (enExample)
BE (1) BE832274A (enExample)
CH (1) CH595344A5 (enExample)
DE (1) DE2535023A1 (enExample)
FR (1) FR2281114A1 (enExample)
GB (1) GB1471809A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
US6022926A (en) * 1997-06-05 2000-02-08 Th. Goldschmidt Ag Organosilanes and organopolysiloxanes containing 2-oxazolidinone groups, their use as surface-active substances and their use for preparing organosilanes and organopolysiloxanes containing amino or carbamido groups

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559022A (ja) * 1991-09-05 1993-03-09 Nippon Paint Co Ltd ５位に置換基を有する２−オキサゾリジノン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1284520A (fr) * 1958-11-03 1962-02-16 American Cyanamid Co Procédé de préparation de nouveaux composés de 2-oxazolidinones
GB893252A (en) * 1959-07-08 1962-04-04 Robins Co Inc A H 5-polysubstituted phenoxymethyl-2-oxazolidones
US3251836A (en) * 1961-09-26 1966-05-17 Szabo Hnos Kessler & Cia S R L Oxazolidone derivatives and their preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
US6022926A (en) * 1997-06-05 2000-02-08 Th. Goldschmidt Ag Organosilanes and organopolysiloxanes containing 2-oxazolidinone groups, their use as surface-active substances and their use for preparing organosilanes and organopolysiloxanes containing amino or carbamido groups

Also Published As

Publication number Publication date
JPS5143757A (ja) 1976-04-14
CH595344A5 (enExample) 1978-02-15
BE832274A (fr) 1976-02-09
FR2281114B1 (enExample) 1978-07-28
FR2281114A1 (fr) 1976-03-05
GB1471809A (en) 1977-04-27

Similar Documents

Publication Publication Date Title
DE2927056C2 (enExample)
LU83982A1 (de) Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel
DE2800954A1 (de) Derivate des meta-trifluoromethylphenylpiperazins und deren verwendung als arzneimittel
AT391864B (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
DE2707095C3 (de) Isopropylaminopyrimidinorthophosphat
DE3852111T3 (de) Galenische Formen von Allergenen für die sublinguale Verabreichung.
DE2158136C2 (de) 4'-Fluor-4-[4-(α - hydroxybenzyl)-piperidino]-butyrophenone, Verfahren zur ihrer Herstellung und ihre Verwendung
DE69625913T2 (de) Inhibitor des erwerbs der abhängigkeit/resistenz gegen betäaubende analgetika
DE1695672C3 (de) 2-MeUIyM-[^- methoxy-carbonyl)-phenylamino] -7-chlorchinolin und dessen Salze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH631893A5 (de) Stabile waessrige oder waessrig-alkoholische loesung von fettloeslichen parfuemoelen oder arzneimitteln.
EP0100037B1 (de) Arzneimittel zur Behandlung von Schlafstörungen
DE2546001B2 (de) Immunostimulierende, Phospholipide enthaltende Stoffgemische, diese Stoffgemische enthaltende Arzneimittel und Verfahren zu ihrer Gewinnung
DD229121A5 (de) Verfahren zur herstellung von pyrrolidinonen
Buchtela et al. Radiogaschromatographie von metallchelaten
DE1443813A1 (de) Verfahren zur Herstellung von neuen basischen Cycloalkanol-AEthern
DE2318025C2 (de) 1-[3-(1-Äthinyl)-2-hydroxy]-propyl-4-phenylpiperazinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2138773C2 (de) 1-(2,2,2-Trifluoroäthyl)-7-chloro-1,3-dihydro-5-phenyl-2 H-1,4-benzodiazepin-2-thione, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE1770187B2 (de) 4- eckige klammer auf n-allyl-n-(2' methoxycarbonylphenyl)-amino eckige klammer zu -7-chlorchinolin, verfahren zu seiner herstellung und therapeutische zusammensetzungen
EP0150721A2 (de) Arzneimittel
DE2057188A1 (de) Erythromycyl-B-amin
DE2445679B2 (de) Stimulierung der Immunität
DE2502684A1 (de) Piperonylpiperazinderivat
DE2227487C3 (de) Derivate von 3-Äthoxycarbonyl-S-hydroxy-2-methyl-4-piperazinomethyl-indol, Verfahren zu ihrer Herstellung und Arzneimittel
DE2048547C3 (de) Krampflösend wirkendes pharmazeutisches Mittel
DE1800823A1 (de) Benzhydrylaether und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
8130 Withdrawal